MADRIGAL PHARMACEUTICALS, INC.·4

Jun 24, 4:34 PM ET

Daly James M 4

4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jun 24, 2025

Insider Transaction Report

Form 4
Period: 2025-06-20
Daly James M
Director
Transactions
  • Award

    Common Stock

    2025-06-20+7152,627 total
  • Award

    Stock Option (Right to Buy)

    2025-06-20+1,2901,290 total
    Exercise: $285.73Exp: 2035-06-20Common Stock (1,290 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided the Reporting Person continues in service with the Issuer on such date.
  • [F2]The option vests as to 100% of underlying shares on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided that the Reporting Person continues to serve as a director of the Issuer until such date.

Documents

1 file
  • 4
    wk-form4_1750797254.xmlPrimary

    FORM 4